Researchers used data from the State Unintentional Drug Overdose Reporting System in order to assess trends in gabapentin-involved overdose deaths.
Pain of any type was a relevant factor for the sequelae of chronic inflammatory demyelinating polyneuropathy.
A secondary analysis sought to identify predictors of pregabalin response in those with chronic posttraumatic neuropathic pain.
A combined unsupervised and supervised machine learning (ML) technique can help predict long-term SCS response for patients with chronic pain.
This meta-analysis aimed to evaluate the advantages and disadvantages of duloxetine compared with gabapentin for diabetic peripheral neuropathic pain.
This prospective case series found that some patients develop neuropathic pain.
Researchers sought to evaluate patients with long COVID who had been referred for peripheral neuropathy evaluations.
Presenting at the 2022 AAN Annual Meeting, researchers evaluated the safety and efficacy of vutrisiran using data from HELIOS-A, an ongoing, 18-month, phase 3 trial.
Some patients with “long COVID” have incident neuropathy.
Researchers tested the safety and efficacy of treating herpes zoster neuralgia with steroid and ozone injection and CT-guided pulsed radiofrequency.